Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival T Hayashi, TP Su Cell 131 (3), 596-610, 2007 | 1890 | 2007 |
MAM: more than just a housekeeper T Hayashi, R Rizzuto, G Hajnoczky, TP Su Trends in cell biology 19 (2), 81-88, 2009 | 863 | 2009 |
The pharmacology of sigma-1 receptors T Maurice, TP Su Pharmacology & therapeutics 124 (2), 195-206, 2009 | 778 | 2009 |
Steroid binding at σ receptors suggests a link between endocrine, nervous, and immune systems TP Su, ED London, JH Jaffe Science 240 (4849), 219-221, 1988 | 683 | 1988 |
Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of … JW Grimm, L Lu, T Hayashi, BT Hope, TP Su, Y Shaham Journal of Neuroscience 23 (3), 742-747, 2003 | 666 | 2003 |
Evidence for sigma opioid receptor: binding of [3H] SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. TP Su Journal of Pharmacology and Experimental Therapeutics 223 (2), 284-290, 1982 | 576 | 1982 |
The sigma-1 receptor chaperone as an inter-organelle signaling modulator TP Su, T Hayashi, T Maurice, S Buch, AE Ruoho Trends in pharmacological sciences 31 (12), 557-566, 2010 | 548 | 2010 |
Regulating ankyrin dynamics: Roles of sigma-1 receptors T Hayashi, TP Su Proceedings of the National Academy of Sciences 98 (2), 491-496, 2001 | 419 | 2001 |
σ-1 receptor ligands: potential in the treatment of neuropsychiatric disorders T Hayashi, TP Su CNS drugs 18, 269-284, 2004 | 391 | 2004 |
Sigma1 (σ1) receptor agonists and neurosteroids attenuate β25–35-amyloid peptide-induced amnesia in mice through a common mechanism T Maurice, TP Su, A Privat Neuroscience 83 (2), 413-428, 1998 | 384 | 1998 |
Ca2+ signaling via ς1-receptors: Novel regulatory mechanism affecting intracellular Ca2+ concentration T Hayashi, T Maurice, TP Su Journal of Pharmacology and Experimental Therapeutics 293 (3), 788-798, 2000 | 358 | 2000 |
Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival T Mori, T Hayashi, E Hayashi, TP Su PloS one 8 (10), e76941, 2013 | 323 | 2013 |
The sigma-1 receptor as a pluripotent modulator in living systems TP Su, TC Su, Y Nakamura, SY Tsai Trends in pharmacological sciences 37 (4), 262-278, 2016 | 314 | 2016 |
σ-1 receptors (σ1 binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization … T Hayashi, TP Su Journal of Pharmacology and Experimental Therapeutics 306 (2), 718-725, 2003 | 303 | 2003 |
Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats Y Wang, YH Chiang, TP Su, T Hayashi, M Morales, BJ Hoffer, SZ Lin Neuropharmacology 39 (5), 873-880, 2000 | 299 | 2000 |
The sigma-1 receptor: roles in neuronal plasticity and disease S Kourrich, TP Su, M Fujimoto, A Bonci Trends in neurosciences 35 (12), 762-771, 2012 | 255 | 2012 |
Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction TP Su, T Hayashi Current medicinal chemistry 10 (20), 2073-2080, 2003 | 250 | 2003 |
The antidepressant-like effect induced by ς1-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test A Urani, FJ Roman, VL Phan, TP Su, T Maurice Journal of Pharmacology and Experimental Therapeutics 298 (3), 1269-1279, 2001 | 240 | 2001 |
Intracellular dynamics of σ-1 receptors (σ1 binding sites) in NG108-15 cells T Hayashi, TP Su Journal of Pharmacology and Experimental Therapeutics 306 (2), 726-733, 2003 | 234 | 2003 |
Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders T Hayashi, SY Tsai, T Mori, M Fujimoto, TP Su Expert opinion on therapeutic targets 15 (5), 557-577, 2011 | 232 | 2011 |